Funding cuts in medical research represent a significant challenge that threatens the integrity of patient safety in studies across the nation.With more than $2 billion in federal grants frozen, the ability to perform critical oversight through institutional review boards (IRBs) is severely hindered, leaving many ongoing clinical trials in limbo.